Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$45.23 - $70.15 $90 - $140
-2 Reduced 18.18%
9 $0
Q1 2022

May 11, 2022

SELL
$54.1 - $110.08 $1,136 - $2,311
-21 Reduced 65.63%
11 $1,000
Q4 2021

Jan 10, 2022

BUY
$94.25 - $115.99 $2,356 - $2,899
25 Added 357.14%
32 $3,000
Q3 2021

Nov 24, 2021

BUY
$80.98 - $109.47 $566 - $766
7 New
7 $1,000
Q2 2021

Jul 30, 2021

SELL
$82.78 - $101.0 $331 - $404
-4 Closed
0 $0
Q1 2021

Apr 29, 2021

SELL
$90.71 - $108.28 $1,269 - $1,515
-14 Reduced 77.78%
4 $0
Q4 2020

Jan 15, 2021

BUY
$92.08 - $124.48 $1,657 - $2,240
18 New
18 $2,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.47B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.